Clinical Trials Browser

Phase 2 × Glioblastoma × infigratinib × Clear all

NCT01975701 2019-12-04

A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

Phase 2 Completed

26 enrolled 10 charts

Glioblastoma